AZN- another potential HGEN lenzilumab competitor fails -
AstraZeneca Cancer Drug Fails to Help Patients With Covid-19 By Marthe Fourcade November 12, 2020, 2:29 AM EST AstraZeneca Plc said its blood-cancer medicine Calquence failed to help patients hospitalized with respiratory symptoms of Covid-19.
The group of patients taking the drug in addition to standard care didn’t show fewer deaths or respiratory failures, the U.K. drugmaker said in a statement. Details of the intermediate clinical trials will be presented in due course, the company said.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.